Ask a Question
Coherent
Search Results
Refine

Result Type

1 - 12 of 25 Products for '577nm' Page 1 of 3 |

577nm

Bio Photonics - October 2015

Bio Photonics - October 2015

…Figure 4. Coherent's Genesis-557 was developed to improve laser photocoagulation outcomes for sufferers of certain forms of macular degeneration. The 577-nm output wavelength matches the absorption maximum of oxyhemoglobin and now dominates this important medical application. Courtesy of Coherent.

Microsoft Word - Document1

Microsoft Word - Document1

Figure 2. The effectiveness of STED is clear in this pair of images of fluorescently tagged microtubuli in mammalian cells using a 577-nm Coherent Genesis laser to drive the STED effect: conventional confocal (left) and gated STED image (right). Image courtesy of Dr. Giuseppe Vicidomini and Dr.…

34706a cover.indd

34706a cover.indd

…to an application has led to the development of a high-power yellow (577nm) laser for the treatment of eye related diseases, such as Age Related Macular Degeneration and retinal diseases associated with diabetes. The 577nm wavelength was designed to match the peak in absorption of oxygenated…

9.27.2014 10K

9.27.2014 10K

…to an application has led to the development of a high-power yellow (577nm) laser for the treatment of eye related diseases, such as Age Related Macular Degeneration and retinal diseases associated with diabetes. The 577nm wavelength was designed to match the peak in absorption of oxygenated…

10.1.2016 10K

10.1.2016 10K

…to an application has led to the development of a high-power yellow (577nm) laser for the treatment of eye related diseases, such as Age Related Macular Degeneration and retinal diseases associated with diabetes. The 577nm wavelength was designed to match the peak in absorption of oxygenated…

9.27.2014 10K

9.27.2014 10K

…to an application has led to the development of a high-power yellow (577nm) laser for the treatment of eye related diseases, such as Age Related Macular Degeneration and retinal diseases associated with diabetes. The 577nm wavelength was designed to match the peak in absorption of oxygenated…

10.3.2015 10K

10.3.2015 10K

…to an application has led to the development of a high-power yellow (577nm) laser for the treatment of eye related diseases, such as Age Related Macular Degeneration and retinal diseases associated with diabetes. The 577nm wavelength was designed to match the peak in absorption of oxygenated…

32311a coverSinglesRR.indd

32311a coverSinglesRR.indd

…to an application has led to the development of a high-power yellow (577nm) laser for the treatment of eye related diseases, such as Age Related Macular Degeneration and retinal diseases associated with diabetes. The 577nm wavelength was designed to match the peak in absorption of oxygenated…

Microsoft Word - Document1

Microsoft Word - Document1

Figure 2. The effectiveness of STED is clear in this pair of images of fluorescently tagged microtubuli in mammalian cells using a 577-nm Coherent Genesis laser to drive the STED effect: conventional confocal (left) and gated STED image (right). Image courtesy of Dr. Giuseppe Vicidomini and Dr.…

32311a coverSinglesRR.indd

32311a coverSinglesRR.indd

…to an application has led to the development of a high-power yellow (577nm) laser for the treatment of eye related diseases, such as Age Related Macular Degeneration and retinal diseases associated with diabetes. The 577nm wavelength was designed to match the peak in absorption of oxygenated…

32311a coverSinglesRR.indd

32311a coverSinglesRR.indd

…to an application has led to the development of a high-power yellow (577nm) laser for the treatment of eye related diseases, such as Age Related Macular Degeneration and retinal diseases associated with diabetes. The 577nm wavelength was designed to match the peak in absorption of oxygenated…

34706a cover.indd

34706a cover.indd

…to an application has led to the development of a high-power yellow (577nm) laser for the treatment of eye related diseases, such as Age Related Macular Degeneration and retinal diseases associated with diabetes. The 577nm wavelength was designed to match the peak in absorption of oxygenated…

Powered by Site Search powered by SLI Systems

Call 1-800-227-8840


Outside the U.S. 1-408-764-4983

Coherent has locations across the globe that are available to provide support for any product, service or inquiry.

Visit our Contact Page to connect with any of our global sites.


Corporate Headquarters
Coherent Inc.
5100 Patrick Henry Drive
Santa Clara, CA 95054 USA

email: tech.sales@coherent.com

Send Us a Message

Please Read Before Continuing

Risk factors: Except for the historical information contained here, many of the matters discussed in this Web site are forward-looking statements, based on expectations at the time they were made, that involve risks and uncertainties that could cause our results to differ materially from those expressed or implied by such statements. These risks are detailed in the “Factors That May Affect Future Results” section of our latest 10-K or 10-Q filing. Coherent assumes no obligation to update these forward-looking statements.


I have read the terms and conditions